Notice Number: NOT-FD-15-005
Key Dates
Release Date: April 13, 2015
Related Announcements
PAR-13-232
Issued by
U.S. Food and Drug Administration (FDA)
Purpose
The purpose of this Notice is to change the Funds Available and Award Budget for PAR-13-232.
Now Reads:
Funds Available and Anticipated Number of Awards |
FDA/CDRH intends to commit up to an estimated amount of $1,100,000 in FY 2013. The number of awards is contingent upon FDA appropriations, and the submission of a sufficient number of meritorious applications. Future year amounts will be contingent on availability of Federal funds but it is estimated that FDA/CDRH will commit up to the following amounts for FY14-17: FY2014: $1,100,000 FY2015: $1,100,000 FY2016: $1,100,000 FY2017: $1,100,000 |
Award Budget |
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs. Year 01: $1,100,000 Year 02: $1,100,000 Year 03: $1,100,000 Year 04: $1,100,000 Year 05: $1,100,000 Funding will be provided for one year, with the possibility of up to four years of additional support. Future year amounts will be contingent on performance and continued availability of federal funds. |
Should Read:
Funds Available and Anticipated Number of Awards |
The anticipated number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations, availability of funding and awardee performance. It is anticipated that any award(s) made will not exceed $3,000,000 in total costs (direct plus indirect), per year, per award. |
Award Budget |
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct plus indirect). Year 01: $3,000,000 Year 02: $3,000,000 Year 03: $3,000,000 Year 04: $3,000,000 Year 05: $3,000,000 Funding will be provided for one year, with the possibility of up to four years of additional support. Future year amounts will depend on annual appropriations, availability of funding and awardee performance. |
Inquiries
Please direct all inquiries to:
Lisa Ko
U.S. Food and Drug Administration (FDA)
Telephone: 240-402-7592
Email: [email protected]